Articles

Results 1 to 5 of 11
Most popular |Most recent


FDA Issues Emergency Use Authorization for COVID-19 Vaccine

USA - December 14 2020 On December 11, 2020, FDA issued the first emergency use authorization (“EUA”) for a vaccine to prevent COVID-19. The vaccine, developed by…

Jamaica Potts Szeliga, Robert S. Terzoli, Jr..

FDA Aggressively Monitoring and Pursuing Advertisements Touting Treatments, Preventions and Cures for COVID-19

USA - July 28 2020 Companies should use caution when making efficacy claims in marketing and advertising of dietary supplements, foods, biological products and other…

Jamaica Potts Szeliga, Robert S. Terzoli, Jr..

Chinese Manufacturers of Personal Protective Equipment Gave False U.S. Agent Information to Food and Drug Administration

China, USA - June 23 2020 U.S. health care providers should closely inspect PPE equipment bought from Chinese companies in light of recent revelations regarding the…

Jamaica Potts Szeliga, Robert S. Terzoli, Jr..

Seyfarth Publishes New Treatise: The Future of Health Care in the US

USA - June 16 2020 (June 16, 2020) - Seyfarth has published a new comprehensive treatise titled, The Future of Health Care in the US: What A Post-Pandemic Health Care…

Adam H. Laughton, Chris DeMeo, Cynthia J. Mitchell, Jamaica Potts Szeliga, Jesse M. Coleman, Kristin G. McGurn, Robert S. Terzoli, Jr., Sheryl Tatar Dacso, William B. Eck.

Can COVID-19 Provide a Sufficient Basis for Claiming Excusable Nonuse of a Trademark?

USA - March 26 2020 As others have previously reported, the US Patent and Trademark Office (USPTO) has taken the position that the COVID-19 pandemic constitutes an…

Julia K. Sutherland, Stephen D. Lott.